Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy

Biological Psychiatry

Volumn 50, Issue 6, 2001, Pages 463-467

  Berg, Daniela ^a   Jabs, Burkhard ^a   Merschdorf, Ursula ^a   Beckmann, Helmut ^a   Becker, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Neuroleptic induced parkinsonism (NIP); Nigrostriatal system; Subclinical injury; Substantia nigra echogenicity; Transcranial ultrasound

Indexed keywords

FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ACUTE PSYCHOSIS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; SYMPTOM;

ACUTE DISEASE; ADULT; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; CORPUS STRIATUM; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035884536     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01190-8     Document Type: Article

References (21)

1. Early onset neuroleptic-induced extrapyramidal reactions: A second survey, 1961-1981
2. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded realtime sonography
3. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
4. Iron accumulation of the substantia nigra in rats visualized by ultrasound
5. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
6. 18F-dopa PET study
7. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients
8. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia
9. Motor and mental aspects of EPS
10. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia
11. Compliance with antipsychotic drug treatment: Influence of side effects
12. Altered brain metabolism of iron as a cause of neurodegenerative diseases
13. Neuroleptic-induced parkinsonism in older schizophrenics
14. Extrapyramidal effects of neuroleptics
15. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs
16. Reversible drug-induced parkinsonism: Clinicopathologic study of two cases
17. Iron induces degeneration of nigrostriatal neurons
18. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
19. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease